![Pfizer Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png?tr=w-200)
Pfizer Inc
NYSE:PFE
![Pfizer Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
25.26
37.01
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Realty Income Corp
NYSE:O
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
US |
![]() |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png)
Intrinsic Value
Pfizer Inc. is a research-based global biopharmaceutical company. [ Read More ]
The intrinsic value of one
PFE
stock under the Base Case scenario is
22.09
USD.
Compared to the current market price of 30.77 USD,
Pfizer Inc
is
Overvalued by 28%.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png?tr=w-200)
Valuation Backtest
Pfizer Inc
Run backtest to discover the historical profit from buying and selling
PFE
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Strong Non-COVID Portfolio Growth and Raised EPS Guidance
Earnings Call Summary
In Q1 2024, Pfizer experienced a 19% operational decline in total revenues due to lower COVID-related sales, totaling $14.9 billion. Yet, excluding COVID products Comirnaty and Paxlovid, the company achieved an 11% operational revenue growth driven by key products Vyndaqel, Eliquis, and Abrysvo. Adjusted earnings per share exceeded expectations at $0.82. Pfizer raised its full-year EPS guidance by $0.10 to a range of $2.15-$2.35. Despite expecting lower operating cash flow in upcoming quarters, Pfizer remains committed to cost management and aims to deliver $4 billion in savings by year-end while projecting annual revenues between $58.5 billion and $61.5 billion.
Balance Sheet Decomposition
Pfizer Inc
Current Assets | 42.4B |
Cash & Short-Term Investments | 11.9B |
Receivables | 15.2B |
Other Current Assets | 15.3B |
Non-Current Assets | 178.7B |
Long-Term Investments | 11.6B |
PP&E | 18.8B |
Intangibles | 132.1B |
Other Non-Current Assets | 16.1B |
Current Liabilities | 40.5B |
Accounts Payable | 5.6B |
Accrued Liabilities | 2.2B |
Short-Term Debt | 7.2B |
Other Current Liabilities | 25.5B |
Non-Current Liabilities | 88.3B |
Long-Term Debt | 61.3B |
Other Non-Current Liabilities | 27B |
Earnings Waterfall
Pfizer Inc
Revenue
|
55.1B
USD
|
Cost of Revenue
|
-16.3B
USD
|
Gross Profit
|
38.8B
USD
|
Operating Expenses
|
-28.2B
USD
|
Operating Income
|
10.6B
USD
|
Other Expenses
|
-11B
USD
|
Net Income
|
-309m
USD
|
Free Cash Flow Analysis
Pfizer Inc
USD | |
Free Cash Flow | USD |
PFE Profitability Score
Profitability Due Diligence
Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png)
Score
Pfizer Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
PFE Solvency Score
Solvency Due Diligence
Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png)
Score
Pfizer Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PFE Price Targets Summary
Pfizer Inc
According to Wall Street analysts, the average 1-year price target for
PFE
is 32.37 USD
with a low forecast of 27.27 USD and a high forecast of 47.25 USD.
Ownership
PFE Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Price Appreciation
PFE Price
Pfizer Inc
Average Annual Return | 13.23% |
Standard Deviation of Annual Returns | 31.42% |
Max Drawdown | -57% |
Market Capitalization | 174.4B USD |
Shares Outstanding | 5 666 590 000 |
Percentage of Shares Shorted | 1.06% |
PFE News
Last Important Events
Pfizer Inc
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Pfizer Inc
Company Profile
![Pfizer Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png?tr=w-200)
![Pfizer Inc Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/nyse/pfe.png?tr=w-200)
Country
Industry
Market Cap
Dividend Yield
Description
Pfizer Inc. is a research-based global biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 79,000 full-time employees. The firm is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. The firm offers therapeutic candidates in gastroenterology, dermatology, and cardiology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator in development for a range of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s Disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata. The firm works across markets to develop wellness, prevention, treatments and cures. The company collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The firm's medicines and vaccines provide value for healthcare providers and patients, through treatment of diseases, improvements in health, wellness.
Contact
IPO
Employees
Officers
The intrinsic value of one
PFE
stock under the Base Case scenario is
22.09
USD.
Compared to the current market price of 30.77 USD,
Pfizer Inc
is
Overvalued by 28%.